Macrocyclic pyrimidine derivatives of general formula I ##STR00001## in which R.sup.1 to R.sup.5, X, Y, A, B, m and n have the meanings that are contained in the description, as inhibitors of the cyclin-dependent kinase, their processes for production as well as their use as medications for treating various diseases are described.

 
Web www.patentalert.com

< Type 1 ryanodine receptor-based methods

> Substituted (4-aminocyclohexen-1-yl)phenyl and (4-aminocyclohexen-1-yl)pyridinyl compounds as 5-HT.sub.1F agonists

~ 00402